단백질체학 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Proteomics Market size is expected to reach USD 144.06 Billion in 2034 from USD 44.79 Billion (2025) growing at a CAGR of 13.86% during 2026-2034.

The global proteomics market has experienced significant growth, driven by advancements in biotechnology and increasing research in life sciences. Proteomics, the large-scale study of proteins, plays a critical role in understanding disease mechanisms and drug development. The rising prevalence of chronic diseases and the need for personalized medicine have accelerated the demand for proteomics technologies, including mass spectrometry and protein microarrays.

Key growth drivers include increased investment in research and development by pharmaceutical and biotechnology companies. Government funding and academic research initiatives also contribute to market expansion. Technological advancements have improved the accuracy and efficiency of protein analysis, enabling deeper insights into cellular processes. Additionally, the growing adoption of proteomics in clinical diagnostics and biomarker discovery supports market growth.

In the future, the proteomics market is expected to expand with the integration of artificial intelligence and big data analytics. These technologies will enhance data interpretation and accelerate research outcomes. Emerging applications in precision medicine and targeted therapies will further drive demand. As the healthcare industry continues to focus on innovation, proteomics will remain a key tool in advancing medical research and improving patient care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

• Instruments
• Reagents & Kits
• Software and Services

By Technique

• Protein Microarray
• X-Ray Crystallography
• Spectroscopy
• Chromatography
• Protein Fractionation
• Electrophoresis
• Surface Plasma Resonance
• Others

By Application

• Drug Discovery & Development
• Clinical Diagnostics
• Cancer Research
• Personalized Medicine
• Others

By End-user

• Biotech & Pharma Companies
• Contract Research Organization (CROs)
• Academic & Research Institutions
• Hospitals & Clinical Laboratories
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Agilent Technologies Inc, Merck KGaA, Illumina Inc, Bruker Corporation, BioRad Laboratories Inc, Waters Corporation, Beckman Coulter Inc, Cell Signaling Technology Inc, Promega Corporation, Danaher Corporation DH Life Sciences LLC, QuantumSi Incorporated, SomaLogic Operating Co Inc, Seer Inc, Nautilus Biotechnology Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PROTEOMICS MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software and Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PROTEOMICS MARKET: BY TECHNIQUE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technique
• 5.2. Protein Microarray Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. X-Ray Crystallography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Spectroscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Protein Fractionation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Surface Plasma Resonance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PROTEOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cancer Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Personalized Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PROTEOMICS MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Biotech & Pharma Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Contract Research Organization (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic & Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Hospitals & Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PROTEOMICS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Component
  • 8.2.2 By Technique
  • 8.2.3 By Application
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Component
  • 8.3.2 By Technique
  • 8.3.3 By Application
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Component
  • 8.4.2 By Technique
  • 8.4.3 By Application
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Component
  • 8.5.2 By Technique
  • 8.5.3 By Application
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Component
  • 8.6.2 By Technique
  • 8.6.3 By Application
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PROTEOMICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Agilent Technologies Inc
  • 10.2.3 Merck KGaA
  • 10.2.4 Illumina Inc
  • 10.2.5 Bruker Corporation
  • 10.2.6 Bio-Rad Laboratories Inc
  • 10.2.7 Waters Corporation
  • 10.2.8 Beckman Coulter Inc
  • 10.2.9 Cell Signaling Technology Inc
  • 10.2.10 Promega Corporation
  • 10.2.11 Danaher Corporation (DH Life Sciences LLC)
  • 10.2.12 Quantum-Si Incorporated
  • 10.2.13 SomaLogic Operating Co. Inc
  • 10.2.14 Seer Inc
  • 10.2.15 Nautilus Biotechnology Inc